X T L Biopharmaceuticals reported $289K in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Bioline Rx USD 294K 183K Jun/2026
Teva Pharmaceutical Industries USD 4.37B 8.3B Sep/2026
X T L Biopharmaceuticals USD 289K 127K Dec/2024